Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: The results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1

Anesthesia and Analgesia

Volumn 105, Issue 4, 2007, Pages 918-925

  Levy, Jerrold H ^a   Mancao, Miguel Y ^b   Gitter, Richard ^c   Kereiakes, Dean J ^d,e   Grigore, Alina M ^f   Aronson, Solomon ^g   Newman, Mark F ^g  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b Sacred Heart Health System   (United States)

^c Trinity Medical Center   (United States)

^d The Carl & Edyth Lindner Center for Research & Education   (United States)

^e CHRIST HOSPITAL   (United States)

^f MAYO CLINIC HOSPITAL   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLEVIDIPINE; ESMOLOL; GLYCERYL TRINITRATE; LIPID EMULSION; METOPROLOL; NICARDIPINE; PLACEBO; VASODILATOR AGENT;

ACUTE KIDNEY FAILURE; ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTERY CATHETERIZATION; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FEVER; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; FEMALE; HEART ATRIUM FIBRILLATION; HEART RATE; HEART SURGERY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CARDIAC SURGICAL PROCEDURES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREOPERATIVE CARE; PYRIDINES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 34748878874     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000281443.13712.b9     Document Type: Article

References (24)

1. Aronson S, Boisvert D, Lapp W. Isolated systolic hypertension is associated with adverse outcomes from coronary artery bypass grafting surgery. Anesth Analg 2002;94:1079-84
2. Weitz HH. Perioperative cardiac complications. Med Clin North Am 2001;85:1151-69
3. Erstad BL, Barletta JF. Treatment of hypertension in the perioperative patient. Ann Pharmacother 2000;34:66-79
4. Leslie JB. Incidence and aetiology of perioperative hypertension. Acta Anaesthesiol Scand Suppl 1993;99:5-9
5. Weiss SJ, Longnecker DE. Perioperative hypertension: an overview. Coron Artery Dis 1993;4:401-6
6. Estafanous FG, Tarazi RC. Systemic arterial hypertension associated with cardiac surgery. Am J Cardiol 1980;46:685-94
7. Vuylsteke A, Feneck RO, Jolin-Mellgård Å, Latimer RD, Levy JH, Lynch C III, Nordlander ML, Nyström P, Ricksten SE. Perioperative blood pressure control: a prospective survey of patient management in cardiac surgery. J Cardiothorac Vasc Anesth 2000;14:269-73
8. Cheung AT. Exploring an optimum intra/postoperative management strategy for acute hypertension in the cardiac surgery patient. J Card Surg 2006;21:S8-14
9. Levy JH. The ideal agent for perioperative hypertension and potential cytoprotective effects. Acta Anaesthesiol Scand Suppl 1993;99:20-5
10. Sladen RN. Perioperative hypertension: what's new and what's useful? In: International Anesthesia Research Society (IARS) 2002 course review lecture. IARS 76th clinical and scientific congress. San Diego, California: International Anesthesia Research Society, 2002:100-8
11. Nordlander M, Sjoquist PO, Ericsson H, Ryden L. Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control. Cardiovasc Drug Rev 2004;22:227-50
12. Kieler-Jensen N, Jolin-Mellgård Å, Nordlander M, Ricksten SE. Coronary and systemic hemodynamic effects of clevidipine, an ultra-short-acting calcium antagonist, for treatment of hypertension after coronary artery surgery. Acta Anaesthesiol Scand 2000;44:186-93
13. Vuylsteke A, Milner Q, Ericsson H, Mur D, Dunning J, Jolin-Mellgård Å, Nordlander M, Latimer R. Pharmacokinetics and pulmonary extraction of clevidipine, a new vasodilating ultrashort-acting dihydropyridine, during cardiopulmonary bypass. Br J Anaesth 2000;85:683-9
14. Ericsson H, Fakt C, Höglund L, Jolin-Mellgård Å, Nordlander M, Sunzel M, Regårdh CG. Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion. Eur J Clin Pharmacol 1999;55:61-7
15. Ericsson H, Bredberg U, Eriksson U, Jolin-Mellgård Å, Nordlander M, Regårdh CG. Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers. Anesthesiology 2000;92:993-1001
16. Bailey JM, Lu W, Levy JH, Ramsay JG, Shore-Lesserson L, Prielipp RC, Brister NW, Roach GW, Jolin-Mellgard A, Nordlander M. Clevidipine in adult cardiac surgical patients: a dose-finding study. Anesthesiology 2002;96:1086-94
17. Schwieler JH, Ericsson H, Löfdahl P, Thulin T, Kahan T. Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans. J Cardiovasc Pharmacol 1999;34:268-74
18. Zhang JG, Dehal SS, Ho T, Johnson J, Chandler C, Blanchard AP, Clark RJ Jr, Crespi CL, Stresser DM, Wong J. Human cytochrome P450 induction and inhibition potential of clevidipine and its primary metabolite H152/81. Drug Metab Dispos 2006;34:734-7
19. Powroznyk AVV, Vuylsteke A, Naughton C, Misso SL, Holloway J, Jolin-Mellgård Å, Latimer RD, Nordlander M, Feneck RO. Comparison of clevidipine with sodium nitroprusside in the control of blood pressure after coronary artery surgery. Eur J Anaesth 2003;20:697-703
20. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Herrmann HC, Hillis LD, Hutter AM Jr, Lytle BW, Marlow RA, Nugent WC, Orszulak TA. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). American College of Cardiology Web site. Available at: http://circ.ahajournals.org/cgi/reprint/110/14/e340.pdf
21. Mack MJ, Brown PP, Kugelmass AD, Battaglia SL, Tarkington LG, Simon AW, Culler SD, Becker ER. Current status and outcomes of coronary revascularization 1999 to 2002: 148,396 surgical and percutaneous procedures. Ann Thorac Surg 2004;77:761-8
22. Lambert CR, Hill JA, Nichols WW, Feldman RL, Pepine CJ. Coronary and systemic hemodynamic effects of nicardipine. Am J Cardiol 1985;55:652-6
23. Leslie J, Brister N, Levy JH, Yared JP, Marty A, Martin H, Hines R, Savino J, Cohen M. Treatment of postoperative hypertension after coronary artery bypass surgery. Double-blind comparison of intravenous isradipine and sodium nitroprusside. Circulation 1994;90:II256-61
24. Mangano DT; Study of Perioperative Ischemia (SPI) Research Group. Dynamic predictors of perioperative risk. J Card Surg 1990;5:231-6